Get the Stockscreener App
1.58
2.47%
-0.04
NanoViricides Inc stock is traded at $1.58, with a volume of 178.66K.
It is down -2.47% in the last 24 hours and up +12.86% over the past month.
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could provide functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
See More
Previous Close:
$1.62
Open:
$1.6
24h Volume:
178.66K
Relative Volume:
0.75
Market Cap:
$25.39M
Revenue:
-
Net Income/Loss:
$-8.29M
P/E Ratio:
-2.2571
EPS:
-0.7
Net Cash Flow:
$-6.47M
1W Performance:
-5.95%
1M Performance:
+12.86%
6M Performance:
+31.67%
1Y Performance:
-24.76%
1-Day Range:
$1.56
$1.62
1-Week Range:
$1.56
$1.72
52-Week Range:
$0.94
$2.34
NanoViricides Inc Stock (NNVC) Company Profile
Name
NanoViricides Inc
Sector
Industry
Phone
203-937-6137
Address
1 Controls Drive, Shelton, CT
Compare NNVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.58 | 26.04M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-15 | Initiated | Midtown Partners | Strong Buy |
NanoViricides Inc Stock (NNVC) Latest News
Will NanoViricides Inc. bounce back from current supportFree Capital Growth With Controlled Risk Picks - Newser
What makes NanoViricides Inc. stock price move sharplySwing Trade Watchlist with Entry Zones - Newser
Heatmap analysis for NanoViricides Inc. and competitorsFree Daily Stock Market Swing Alerts - Newser
Published on: 2025-08-01 04:46:47 - Newser
Real time breakdown of NanoViricides Inc. stock performanceRisk Shielded Trade Watch with Analysis - Newser
Using Python tools to backtest NanoViricides Inc. strategiesDaily Investment Ideas with Market Insight - Newser
Is NanoViricides Inc. Stock a Smart Buy in 2025 Investment Analysis InsideSmart Trade Forecast Based on Neural Logic - Newser
What momentum shifts mean for NanoViricides Inc.AI Powered Stock Market Trend Forecast - Newser
Will NanoViricides Inc. outperform the marketStock Forecast Tools for Retail Traders - Newser
What are the latest earnings results for NanoViricides Inc.Expert Picks Target Finder For Consistent Profits - jammulinksnews.com
Why NanoViricides Inc. stock attracts strong analyst attentionDaily Market Entry Strategy with Tools - Newser
What institutional investors are buying NanoViricides Inc. stockSwing Trade Outlook For Every Investor - jammulinksnews.com
NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value - Petoskey News-Review
Signal strength of NanoViricides Inc. stock in tech scannersFree Chart Driven High Reward Trading Setup - Newser
How to forecast NanoViricides Inc. trends using time seriesFree Fast Gaining Stock Screener Report - Newser
Backtesting results for NanoViricides Inc. trading strategiesFree News Based Entry Opportunity Alerts - Newser
Global Measles Crisis: NanoViricides Advances Revolutionary Treatment as Cases Hit 25-Year High in Europe - Stock Titan
NanoViricides says antiviral candidate NV-387 could address global measles surge - Proactive financial news
Published on: 2025-07-30 10:45:34 - metal.it
NanoViricides Inc. Facing Inflection Point in Trend AnalysisTriple Digit Return Stock Predictions Released - metal.it
Published on: 2025-07-29 09:28:26 - metal.it
How volatile is NanoViricides Inc. stock compared to the marketPost Market Guidance With High Returns - jammulinksnews.com
What markets is NanoViricides Inc. expanding into Is NVST stock a good long term investment optionMaximize your portfolio’s growth with expert tips - jammulinksnews.com
What are NanoViricides Inc. company’s key revenue driversFree Investment Community - jammulinksnews.com
What markets is PBPB expanding into Is NanoViricides Inc. stock a good long term investment optionBreakthrough capital growth - jammulinksnews.com
Published on: 2025-07-28 05:51:59 - Newser
What makes NanoViricides Inc. stock price move sharply Growth Watchlist for Long Term Positioning - Newser
Should you hold or exit NanoViricides Inc. now AI-Based Stock Behavior Forecast Engine - Newser
How many analysts rate NanoViricides Inc. as a “Buy”Maximize returns with smart investment plans - jammulinksnews.com
Is it the right time to buy NanoViricides Inc. stockCapitalize on emerging market opportunities - jammulinksnews.com
What is the risk reward ratio of investing in NanoViricides Inc. stockBuild wealth faster with disciplined trading - jammulinksnews.com
NanoViricides Inc Stock (NNVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):